| Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent A Mazzoni, L Salvati, L Maggi, M Capone, A Vanni, M Spinicci, ... The Journal of clinical investigation 130 (9), 4694-4703, 2020 | 522 | 2020 |
| First-dose mRNA vaccination is sufficient to reactivate immunological memory to SARS-CoV-2 in subjects who have recovered from COVID-19 A Mazzoni, N Di Lauria, L Maggi, L Salvati, A Vanni, M Capone, ... The Journal of clinical investigation 131 (12), 2021 | 133 | 2021 |
| Metabolomic/lipidomic profiling of COVID-19 and individual response to tocilizumab G Meoni, V Ghini, L Maggi, A Vignoli, A Mazzoni, L Salvati, M Capone, ... PLoS Pathogens 17 (2), e1009243, 2021 | 86 | 2021 |
| Compassionate use of JAK1/2 inhibitor ruxolitinib for severe COVID-19: a prospective observational study AM Vannucchi, B Sordi, A Morettini, C Nozzoli, L Poggesi, F Pieralli, ... Leukemia 35 (4), 1121-1133, 2021 | 79 | 2021 |
| Cell‐mediated and humoral adaptive immune responses to SARS‐CoV‐2 are lower in asymptomatic than symptomatic COVID‐19 patients A Mazzoni, L Maggi, M Capone, M Spinicci, L Salvati, MG Colao, A Vanni, ... European Journal of Immunology 50 (12), 2013-2024, 2020 | 69 | 2020 |
| Quantitative and qualitative alterations of circulating myeloid cells and plasmacytoid DC in SARS‐CoV‐2 infection B Peruzzi, S Bencini, M Capone, A Mazzoni, L Maggi, L Salvati, A Vanni, ... Immunology 161 (4), 345-353, 2020 | 67 | 2020 |
| Prompt predicting of early clinical deterioration of moderate-to-severe COVID-19 patients: usefulness of a combined score using IL-6 in a preliminary study A Vultaggio, E Vivarelli, G Virgili, E Lucenteforte, A Bartoloni, C Nozzoli, ... The Journal of Allergy and Clinical Immunology: In Practice 8 (8), 2575-2581. e2, 2020 | 66 | 2020 |
| The impact of targeted therapies and immunotherapy in melanoma brain metastases: a systematic review and meta‐analysis E Rulli, L Legramandi, L Salvati, M Mandala Cancer 125 (21), 3776-3789, 2019 | 64 | 2019 |
| Hallmarks of immune response in COVID-19: Exploring dysregulation and exhaustion A Mazzoni, L Salvati, L Maggi, F Annunziato, L Cosmi Seminars in Immunology 55, 101508, 2021 | 55 | 2021 |
| From emollients to biologicals: targeting atopic dermatitis L Salvati, L Cosmi, F Annunziato International journal of molecular sciences 22 (19), 10381, 2021 | 38 | 2021 |
| SARS-CoV-2 spike-specific CD4+ T cell response is conserved against variants of concern, including omicron A Mazzoni, A Vanni, M Spinicci, M Capone, G Lamacchia, L Salvati, ... Frontiers in Immunology 13, 801431, 2022 | 37 | 2022 |
| SARS-CoV-2 infection and vaccination trigger long-lived B and CD4+ T lymphocytes with implications for booster strategies A Mazzoni, A Vanni, M Spinicci, G Lamacchia, ST Kiros, A Rocca, ... The Journal of Clinical Investigation 132 (6), 2022 | 35 | 2022 |
| A gendered magnifying glass on COVID-19 L Salvati, B Biagioni, E Vivarelli, P Parronchi Clinical and Molecular Allergy 18, 1-11, 2020 | 28 | 2020 |
| Clinical and immunological features of SARS-CoV-2 breakthrough infections in vaccinated individuals requiring hospitalization G Lamacchia, A Mazzoni, M Spinicci, A Vanni, L Salvati, B Peruzzi, ... Journal of Clinical Immunology 42 (7), 1379-1391, 2022 | 26 | 2022 |
| Heterogeneous magnitude of immunological memory to SARS‐CoV‐2 in recovered individuals A Mazzoni, L Maggi, M Capone, A Vanni, M Spinicci, L Salvati, ... Clinical & Translational Immunology 10 (5), e1281, 2021 | 26 | 2021 |
| Gender differences in anaphylaxis L Salvati, G Vitiello, P Parronchi Current Opinion in Allergy and Clinical Immunology 19 (5), 417-424, 2019 | 24 | 2019 |
| Effectiveness and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps and associated comorbidities: a multicentric prospective study in real life E Nettis, L Brussino, V Patella, L Bonzano, A Detoraki, E Di Leo, ... Clinical and Molecular Allergy 20 (1), 6, 2022 | 23 | 2022 |
| Quality of life in patients with allergic and immunologic skin diseases: in the eye of the beholder E Di Agosta, L Salvati, M Corazza, I Baiardini, F Ambrogio, L Angileri, ... Clinical and Molecular Allergy 19, 1-17, 2021 | 21 | 2021 |
| Pulmonary vascular improvement in severe COVID-19 patients treated with tocilizumab L Salvati, M Occhipinti, L Gori, L Ciani, A Mazzoni, L Maggi, M Capone, ... Immunology Letters 228, 122-128, 2020 | 20 | 2020 |
| The burden of cutaneous adnexal carcinomas and the risk of associated squamous cell carcinoma: a population‐based study V De Giorgi, L Salvati, A Barchielli, A Caldarella, A Gori, F Scarfì, ... British Journal of Dermatology 180 (3), 565-573, 2019 | 19 | 2019 |
